Tax News Update    Email this document    Print this document  

June 17, 2022
2022-0942

Senate HELP Committee advances user fee agreements and three public health bills to full Senate

On June 14, the Senate Health, Education, Labor, and Pensions Committee advanced four health care bills to the full Senate, including legislation to reauthorize the Food and Drug Administration’s (FDA) user fee agreements, the FDA Safety and Landmark Advancements Act (FDASLA).

If passed, the Senate will need to reconcile the FDASLA with the House’s FDA User Fee Reauthorization package (H.R. 7667), which passed in a 392-28 vote under suspension of the rules on June 8. During the Senate markup, lawmakers debated 39 amendments to FDASLA, ultimately adopting 28 amendments, including several addressing the current infant formula shortage, new transparency requirements for the FDA, increasing generic drug competition, and allowing prescription drug importation from Canada. Lawmakers voted 15-7 to table a broader drug importation amendment from Sen. Bernie Sanders (D-VT) that would have allowed wholesalers, licensed US pharmacies, and individuals to import prescription drugs from the United Kingdom and Canada, with the potential for additional countries over time. Several Republicans, including Ranking Member Richard Burr (R-NC), raised concerns that the measure’s inclusion would jeopardize the bill’s overall passage.

The committee also voted to advance three public health bills: the Maximizing Outcomes through Better Investments in Lifesaving Equipment for (MOBILE) Health Care Act (S. 958), the Cardiovascular Advances in Research and Opportunities Legacy Act (H.R. 1193), and the Early Hearing Detection and Intervention Act of 2022 (S. 4052).

More information is available here.

Additional information is also available in the attached Tax Alert.

———————————————

Contact Information
For additional information concerning this Alert, please contact:
 
Washington Council Ernst & Young
   • Heather Meade (heather.meade@ey.com)
   • Heather Bell (heather.bell@ey.com)

———————————————
ATTACHMENT

HELP Committee advances health care bills

 

The information contained herein is general in nature and is not intended, and should not be construed, as legal, accounting or tax advice or opinion provided by Ernst & Young LLP to the reader. The reader also is cautioned that this material may not be applicable to, or suitable for, the reader's specific circumstances or needs, and may require consideration of non-tax and other tax factors if any action is to be contemplated. The reader should contact his or her Ernst & Young LLP or other tax professional prior to taking any action based upon this information. Ernst & Young LLP assumes no obligation to inform the reader of any changes in tax laws or other factors that could affect the information contained herein.

 

Copyright © 1996 – 2024, Ernst & Young LLP

 

All rights reserved. No part of this document may be reproduced, retransmitted or otherwise redistributed in any form or by any means, electronic or mechanical, including by photocopying, facsimile transmission, recording, rekeying, or using any information storage and retrieval system, without written permission from Ernst & Young LLP.

 

EY US Tax News Update Master Agreement | EY Privacy Statement